MXPA05005762A - Procedimiento para preparar compuestos activos opticamente puros. - Google Patents

Procedimiento para preparar compuestos activos opticamente puros.

Info

Publication number
MXPA05005762A
MXPA05005762A MXPA05005762A MXPA05005762A MXPA05005762A MX PA05005762 A MXPA05005762 A MX PA05005762A MX PA05005762 A MXPA05005762 A MX PA05005762A MX PA05005762 A MXPA05005762 A MX PA05005762A MX PA05005762 A MXPA05005762 A MX PA05005762A
Authority
MX
Mexico
Prior art keywords
optically pure
active compounds
preparing optically
pure active
chiral
Prior art date
Application number
MXPA05005762A
Other languages
English (en)
Inventor
Steffen Weingart Ralf
Original Assignee
Altana Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altana Pharma Ag filed Critical Altana Pharma Ag
Publication of MXPA05005762A publication Critical patent/MXPA05005762A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)
  • Catalysts (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)

Abstract

La invencion se refiere a un procedimiento novedoso para preparar PPI opticamente puro que tiene una estructura de sulfinilo utilizando un complejo de zirconio quiral o un complejo de hafnio quiral.
MXPA05005762A 2002-12-06 2003-12-03 Procedimiento para preparar compuestos activos opticamente puros. MXPA05005762A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02027273 2002-12-06
DE10340255 2003-08-29
PCT/EP2003/013605 WO2004052882A1 (en) 2002-12-06 2003-12-03 Process for preparing optically pure active compounds

Publications (1)

Publication Number Publication Date
MXPA05005762A true MXPA05005762A (es) 2005-08-16

Family

ID=32509784

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005762A MXPA05005762A (es) 2002-12-06 2003-12-03 Procedimiento para preparar compuestos activos opticamente puros.

Country Status (28)

Country Link
US (1) US7452998B2 (es)
EP (1) EP1578742B1 (es)
JP (1) JP4612542B2 (es)
KR (1) KR101062806B1 (es)
CN (1) CN100482658C (es)
AR (1) AR042277A1 (es)
AU (1) AU2003289948B2 (es)
BR (2) BR0317005A (es)
CA (1) CA2507807C (es)
CY (1) CY1114058T1 (es)
DK (1) DK1578742T3 (es)
EA (1) EA011771B1 (es)
ES (1) ES2397380T3 (es)
HK (1) HK1078864A1 (es)
HR (1) HRP20050604B1 (es)
IL (1) IL168456A (es)
IS (1) IS2885B (es)
ME (1) ME00563A (es)
MX (1) MXPA05005762A (es)
NO (1) NO330978B1 (es)
NZ (1) NZ540815A (es)
PL (1) PL375818A1 (es)
PT (1) PT1578742E (es)
RS (1) RS52667B (es)
SI (1) SI1578742T1 (es)
TW (1) TWI313268B (es)
WO (1) WO2004052882A1 (es)
ZA (1) ZA200503543B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2384160T3 (es) 1999-01-13 2012-07-02 Bayer Healthcare Llc Difenil ureas sustituidas con omega-carboxi arilo como agentes inhibidores de la cinasa p38
DK1575941T3 (da) 2002-12-06 2012-07-09 Nycomed Gmbh Fremgangsmåde til fremstilling af (S)-pantoprazol
FR2848555B1 (fr) * 2002-12-16 2006-07-28 Negma Gild Enantiomere(-)du tenatoprazole et son application en therapeutique
JP2006514108A (ja) * 2002-12-19 2006-04-27 テバ ファーマシューティカル インダストリーズ リミティド パントプラゾールナトリウムの固体状態、それらの調製方法、及び公知のパントプラゾールナトリウム水和物の調製方法
US7683177B2 (en) * 2003-06-10 2010-03-23 Teva Pharmaceutical Industries Ltd Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
MXPA06013623A (es) * 2004-06-02 2007-02-28 Altana Pharma Ag Procedimiento para la preparacion de compuestos piridin-2-ilmetilsulfinil-1h-benzimidazol.
FR2871800B1 (fr) * 2004-06-17 2006-08-25 Sidem Pharma Sa Sa Sel de sodium monohydrate du s-tenatoprazole et application en therapeutique
AU2005257709C1 (en) * 2004-06-24 2011-02-24 Astrazeneca Ab New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
EP1801110A1 (en) 2005-12-22 2007-06-27 KRKA, tovarna zdravil, d.d., Novo mesto Esomeprazole arginine salt
US7579476B2 (en) * 2006-02-24 2009-08-25 Praktikatalyst Pharma, Llc Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals
WO2008018091A1 (en) * 2006-08-08 2008-02-14 Jubilant Organosys Limited Process for producing sulphoxide compounds
WO2008047681A1 (fr) 2006-10-13 2008-04-24 Eisai R & D Management Co., Ltd. Benzimidazole présentant une activité inhibitrice de la sécrétion d'acide gastrique
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
CA2717578A1 (en) * 2008-03-18 2009-09-24 Dr. Reddy's Laboratories Ltd. Dexlansoprazole process and polymorphs
EP2143722A1 (en) 2008-07-09 2010-01-13 Lek Pharmaceuticals D.D. Process for preparation of esomeprazole sodium of high chemical purity and new forms of esomeprazole sodium
EP2264024A1 (en) 2008-10-14 2010-12-22 LEK Pharmaceuticals d.d. Process for the preparation of enantiomerically enriched proton pump inhibitors
US8071781B2 (en) * 2008-11-11 2011-12-06 Syn-Tech Chem. & Pharm. Co., Ltd. Process for preparing rabeprazole sodium
CA2789298A1 (en) 2010-02-12 2011-08-18 Esteve Quimica, S.A. Preparation process of the sodium salt of esomeprazole
CN103113351B (zh) * 2013-03-08 2015-01-21 苏州特瑞药业有限公司 一种光学纯手性亚砜类化合物的制备方法
CN103936714A (zh) * 2014-04-15 2014-07-23 北京华禧联合科技发展有限公司 一种埃索美拉唑镁的制备方法
KR20170098843A (ko) * 2014-12-26 2017-08-30 고쿠리츠다이가쿠호우진 도쿄다이가쿠 광학 활성의 프로톤 펌프 저해 화합물의 제조 방법
CN105440018A (zh) * 2015-11-27 2016-03-30 福州闽海药业有限公司 一种锆催化的右旋兰索拉唑的不对称氧化合成方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IL75400A (en) 1984-06-16 1988-10-31 Byk Gulden Lomberg Chem Fab Dialkoxypyridine methyl(sulfinyl or sulfonyl)benzimidazoles,processes for the preparation thereof and pharmaceutical compositions containing the same
JPS6150978A (ja) 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
FI90544C (fi) 1986-11-13 1994-02-25 Eisai Co Ltd Menetelmä lääkeaineina käyttökelpoisten 2-pyridin-2-yyli-metyylitio- ja sulfinyyli-1H-bensimidatsolijohdannaisten valmistamiseksi
SE465514B (sv) 1990-02-19 1991-09-23 Curt Pettersson Foerfarande och anvaendning av ett separationsmedium vid separation av enantiomerer
DE4035455A1 (de) 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung
JPH08509736A (ja) 1993-04-27 1996-10-15 セプラコー，インコーポレイテッド 光学的に純粋な（−）パントプラゾールを用いる胃の疾患治療の方法と組成
CA2161130A1 (en) 1993-04-27 1994-11-10 Nancy M. Gray Methods and compositions for treating gastric disorders using optically pure (+) pantoprazole
SE9301830D0 (sv) 1993-05-28 1993-05-28 Ab Astra New compounds
SE504459C2 (sv) * 1994-07-15 1997-02-17 Astra Ab Förfarande för framställning av substituerade sulfoxider
GB9423968D0 (en) 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) 1994-11-28 1995-01-11 Astra Ab Oxidation
HRP960232A2 (en) 1995-07-03 1998-02-28 Astra Ab A process for the optical purification of compounds
DK1575941T3 (da) 2002-12-06 2012-07-09 Nycomed Gmbh Fremgangsmåde til fremstilling af (S)-pantoprazol

Also Published As

Publication number Publication date
JP4612542B2 (ja) 2011-01-12
CA2507807C (en) 2013-10-22
KR101062806B1 (ko) 2011-09-07
HRP20050604A2 (en) 2006-09-30
HK1078864A1 (en) 2006-03-24
EP1578742A1 (en) 2005-09-28
EA011771B1 (ru) 2009-06-30
CN1717403A (zh) 2006-01-04
TW200508219A (en) 2005-03-01
AU2003289948B2 (en) 2009-12-24
NO20053099L (no) 2005-06-24
SI1578742T1 (sl) 2013-02-28
DK1578742T3 (da) 2013-01-21
ME00563A (en) 2011-12-20
WO2004052882A1 (en) 2004-06-24
US20050288334A1 (en) 2005-12-29
NO20053099D0 (no) 2005-06-24
EA200500898A1 (ru) 2005-12-29
BRPI0310118B1 (pt) 2015-10-20
AR042277A1 (es) 2005-06-15
JP2006516261A (ja) 2006-06-29
IL168456A (en) 2012-02-29
RS20050423A (en) 2007-04-10
ES2397380T3 (es) 2013-03-06
NO330978B1 (no) 2011-08-29
EP1578742B1 (en) 2012-10-17
PT1578742E (pt) 2013-01-24
KR20050085224A (ko) 2005-08-29
IS2885B (is) 2014-07-15
CY1114058T1 (el) 2016-07-27
ZA200503543B (en) 2006-08-30
BR0317005A (pt) 2005-10-25
PL375818A1 (en) 2005-12-12
TWI313268B (en) 2009-08-11
CA2507807A1 (en) 2004-06-24
CN100482658C (zh) 2009-04-29
HRP20050604B1 (hr) 2013-09-30
IS7909A (is) 2005-06-23
US7452998B2 (en) 2008-11-18
RS52667B (en) 2013-06-28
AU2003289948A1 (en) 2004-06-30
NZ540815A (en) 2008-03-28

Similar Documents

Publication Publication Date Title
TW200508219A (en) Process for preparing optically pure active compounds
TW200621151A (en) Optically active phthalamides
SI1509517T1 (sl) Nova sinteza irbesartana
TW200510376A (en) Process for preparing (s)-pantoprazole
SG148154A1 (en) Benzannelated compounds as ppar activators
TW200624435A (en) Process for preparing iridium(Ⅲ) ketoketonates
AU2003297748A1 (en) A process for the co-production of alcohols
PT1357932E (pt) Modificacao cristalina de um depsipeptido ciclico com eficacia melhorada
ATE411310T1 (de) Reinigungsverfahren von moxonidine
AU2003276330A8 (en) Novel compounds comprising a thiocarbonyl-sulfanyl group, which can be used for the radical synthesis of alpha-perfluoroalkylamines
IL164901A (en) Process for preparing optically active beta-aminoketones
SI1704140T1 (sl) Postopek za pripravo (R)-5-(2-aminopril)-2-metoksibenzensulfonamida
MXPA04003085A (es) Proceso estereoespecifico para sintesis de derivados de 2-il cromano.
AU2003215640A1 (en) Process for preparing optically active beta-aminocarboxylic acids from racemic n-acylated beta-aminocarboxylic acids
AU2003230438A1 (en) Process for preparing optically pure 3-hydroxy-pyrrolidine
TW200407314A (en) Preparation of 4, 6-dichloro-5-fluoropyrimidine
AU2003221313A1 (en) Novel organosilicon compound, optically active isomers thereof, process for producing the organosilicon compound, and use thereof
AU2003284394A1 (en) Process for producing optically active hydroxylactam compound
MX2007012472A (es) (+)-y-(-)-8-alquil-3-(trifluoralquilsulfoniloxi)-8-azabicicl (3.2.1)cot-2-eno.
AU2003284450A1 (en) Process for producing optically active 1-cyclohexyl-2-propyn-1-ol
AU2003261978A1 (en) Process for producing optically active erythro 3-cyclohexylserines
FI20020502A0 (fi) Menetelmä aktiivista happea sisältävän kalkkituotteen valmistamiseksi
AU2002247980A1 (en) Process for the synthesis of cumene hydroperoxide
AU2003221314A1 (en) Novel organosilicon compounds, process for production thereof, and optically active substances of the compounds
EP1482054A4 (en) PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE ALLAS

Legal Events

Date Code Title Description
HC Change of company name or juridical status
FG Grant or registration
HC Change of company name or juridical status